Ophthalmology

$1 million is up for grabs

Babies exposed to marijuana in the womb may require clinical care sooner.

Reassurance should focus on success rates and low risk of serious problems.

Acute intraocular inflammation was less common for ranibizumab than aflibercept.

Perceived Stress Scale worked well in assessing stress levels of AMD patients.

Review explores reducing corticosteroid use with immunomodulatory therapies.

In a long-term study, surgery was better than medical care alone for diabetes.

People with noninfectious uveitis tend to have low vitamin D levels.

Between 2012 and 2015, pod-related eye burns among toddlers increased 3000%.

Report underscores the need to act quickly, refer patients with eye problems.

T. gondii is one of the most common causes of infectious posterior uveitis.

In a new study, stroke occurred in 6.6% of the ranibizumab-treated group, compared with 7.0% of the controls matched by sociodemographic factors and comorbidities and 6.7% of the controls matched by sociodemographic factors only. These differences were not statistically significant.

A Spanish research team found an association between testing positive for antibodies to adalimumab (Humira) and a worse outcome of uveitis, but only in those who tested positive permanently. They also found that this association correlated with undetectable trough levels of Humira.

Monthly Avastin injections and quarterly Ozurdex injections produced equivalent improvements in best-corrected visual acuity after 7 months. However, Ozurdex reduced central subfield thickness nine times more than Avastin did, though it was associated with elevated intraocular pressure.

Patients with intermediate uveitis (IU) have a high likelihood of achieving good long-term visual outcomes, but should expect a long disease course and frequent complications

Adalimumab (ADA) works well as a treatment for patients with both active and inactive uveitis whether or not they are taking an immunosuppressant (IMM); however, the median time to treatment failure (mTTF) is longer for patients with inactive uveitis taking an IMM.

As with most surgical advances, new potential procedures in ophthalmology pose their fair share of risks. However, if those risks can be overcome the rewards to patients can make a significant difference in their quality of life.

Medical technology is constantly evolving across fields, and ophthalmology is no exception. A new hypersonic vitrectomy device is currently in development and could be on the market in 2017.

Before antibiotics, people went blind from syphilis. They still could, the US Centers for Disease Control and Prevention warned today.

Personality traits such as being calm and organized are associated with types of uveitis, researchers in India found.

Much in the way GPS systems help drivers navigate the roads easier, image guided surgery can help doctors provide better care to their patients in many cases.

The mortality rate of AMD patients who received a bevacizumab injection 3 or 6 months after stroke was, in the study’s words, “worrying” compared to the rate of those who did not.

Explaining diabetic macular edema to patients can be a challenge in itself. Going further to explain the injection process can take even more care for eye care professionals.

Difluprednate, a steroid stronger than prednisolone, was recently tested for treatment of macular edema and vitritis in cases of posterior/intermediate uveitis, and its impact was noticeable.

Uveitis can have many causes. In a newly reported case study in the New England Journal of Medicine, a team from Korea reports on a patient with worms in his eye. There's a video.